ConductScience.org, home

Gene · 3598

Papers2,877

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

101 to 120 of 2,877

Download this page as JSON
TitleJournalYearPMIDFound bySource
Challenges and breakthroughs: current landscape and future prospects of CAR-T cell therapy clinical trials for solid tumors.Front Oncol202540969260PubTator, text miningPubMed
Screening and Validation of Genes Associated With Lysosomal-Dependent Cell Death in Colorectal Cancer.Mol Carcinog202540964747PubTator, text miningPubMed
CAR T-cell and oncolytic virus dynamics and determinants of combination therapy success for glioblastoma.Math Biosci202540962204PubTator, text miningPubMed
Promising Cancer Vaccine for Glioblastoma Therapy: A Focus on mRNA Vaccine.Cancer Med202540948290PubTator, text miningPubMed
Evolving therapeutic strategies in glioblastoma: traditional approaches and novel interventions.3 Biotech202540893155PubTator, text miningPubMed
Recent advances in universal chimeric antigen receptor T cell therapy.J Hematol Oncol202540883768PubTator, text miningPubMed
IL-13/IL-13Rα2 axis promotes proliferation of angiosarcoma cells.Sci Rep202540855097PubTator, text miningPubMed
Dual roles and therapeutic targeting of tumor-associated macrophages in tumor microenvironments.Signal Transduct Target Ther202540850976PubTator, text miningPubMed
GD2: hopes and challenges for the treatment of pediatric patients with tumors of the central nervous system.NPJ Precis Oncol202540835729PubTator, text miningPubMed
Atopic Dermatitis Management: from Conventional Therapies to Biomarker-Driven Treatment Approaches.Biomol Ther (Seoul)202540827120PubTator, text miningPubMed
Computational structural optimization enhances IL13Rα2 - B7-H3 tandem CAR T cells to overcome antigen-heterogeneity-mediated tumor escape.Mol Ther202540812316PubTator, text miningPubMed
Bioinformatics-based prognostic value and in vitro functional validation of PTK6 in cutaneous melanoma.Front Oncol202540809015PubTator, text miningPubMed
IL-7 armed binary CAR T cell strategy to augment potency against solid tumors.Front Immunol202540808942PubTator, text miningPubMed
Novel IL13RA2-targeted immunocytokines exhibit superior antitumor activities.Acta Pharmacol Sin202540797114PubTator, text miningPubMed
CREB5 promotes tumorigenicity and upregulates druggable cell surface modalities in basal-like breast cancer.NPJ Precis Oncol202540770411PubTator, text miningPubMed
Nanomaterials engineered for photothermal therapy in neural tumors and neurodegenerative diseases: biomaterial design, clinical mechanisms and applications.Front Bioeng Biotechnol202540761545PubTator, text miningPubMed
RNA Epigenetics in Cancer: Current Knowledge and Therapeutic Implications.MedComm (2020)202540761481PubTator, text miningPubMed
Interleukin Family-Based Signature Relates to Cancer-Associated Fibroblasts Spatial Distribution and Immune Therapy Response in Pancreatic Carcinoma.J Inflamm Res202540761382PubTator, text miningPubMed
Combining mucosal microbiome and host multi-omics data shows prognostic potential in paediatric ulcerative colitis.Nat Commun202540759968PubTator, text miningPubMed
Immunotherapy in Glioblastoma: An Overview of Current Status.Clin Pharmacol202540735070PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/3598/papers?page=6